Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acetazolamide and Tubuloglomerular Feedback in Persons With Type 1 Diabetes: A Dose Finding Clinical Trial

NCT05473364 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05473364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05473364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acetazolamide and Tubuloglomerular Feedback in Persons With Type 1 Diabetes: A Dose Finding Clinical Trial
Lead sponsor
University of California, San Diego
Phase
Phase 1/2
Overall status
Completed
Start date
March 20, 2023
Completion date
July 31, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes